A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease
Clinical trial NCT00552344 · COMPLETED
Trial details
- NCT number
- NCT00552344
- Sponsor
- UCB BIOSCIENCES GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2014-12-01
- Enrollment
- 403
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.